Jaka jest cena za Apollo Endosurgery, Inc. (APEN)

Cena za Apollo Endosurgery, Inc. (APEN) wynosi $10.00

Jaka jest kapitalizacja rynkowa dla Apollo Endosurgery, Inc. (APEN)

Kapitalizacja rynkowa dla Apollo Endosurgery, Inc. (APEN) wynosi $214.01M

Apollo Endosurgery, Inc. (APEN) Marża Operacyjna

Apollo Endosurgery, Inc. is a medical technology firm specializing in the creation, development, and commercialization of advanced medical instruments. Among its products are the OverStitch and OverStitch Sx Endoscopic Suturing Systems, which empower physicians to perform advanced endoscopic procedures by suturing and securing tissue approximation via a flexible endoscope. The company also features the Orbera intragastric balloon system, available under brands such as Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System. This system aids in weight management by decreasing stomach capacity and slowing gastric emptying, thereby encouraging reduced food intake. Additionally, it provides the X-Tack Endoscopic HeliX Tacking System, a suture-based device designed for repairing defects in both the upper and lower gastrointestinal tract. Its medical solutions are distributed to various healthcare providers, including hospitals, outpatient surgical centers, clinics, and individual physicians, across the United States, Australia, Costa Rica, and several European nations. Founded in 2005, Apollo Endosurgery, Inc. maintains its headquarters in Austin, Texas.

Rok	Marża operacyjna	Zmień
Za mało danych dla podanych dat.

Rok

Marża operacyjna

Zmień

Za mało danych dla podanych dat.

Firma	Marża operacyjna	Różnica w marży operacyjnej	Kraj
Abbott Laboratories ABT.US	17.03%	-	US
Stryker Corporation SYK.US	22.03%	-	US
Medtronic plc MDT.US	17.86%	-	IE
Boston Scientific Corporation BSX.US	21.46%	-	US
Edwards Lifesciences Corporation EW.US	28.09%	-	US

Firma

Marża operacyjna

Różnica w marży operacyjnej

Kraj